Major Health Organizations in China Install ZOLL Defibrillators

* Reuters is not responsible for the content in this press release.

Tue Aug 5, 2008 7:00pm EDT

CHELMSFORD, Mass.--(Business Wire)--
ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of
resuscitation devices and related software solutions, announced today
that the ZOLL M Series(R) defibrillator has been installed in a number
of high profile EMS centers and hospitals in the People's Republic of
China.

   Over 250 M Series have been installed in both ambulances and
hospitals in Beijing over the past 18 months to service the Summer
Olympic Games and help improve the city's emergency service levels. In
Shanghai, the largest city in China, the M Series has been selected to
equip the city's newly-expanded ambulance service. To date, the
Shanghai Medical Emergency Service Center has placed 145 M Series into
service in the metropolitan area.

   In addition, ZOLL was awarded a Beijing government public tender
to install 191 AED Plus(R) units into Community Medical Service
Centers in Beijing City. This project marks the first time that AEDs
are being made available to local residents in China through health
centers and clinics. This is an integral part of China's new
healthcare system, which is designed to provide healthcare and first
rescue response at the community level.

   "China represents an important future market opportunity for ZOLL.
Although modest in proportion to our consolidated results, over the
past two years, our growth in China has exceeded 100 percent," said
Richard A. Packer, Chairman and Chief Executive Officer of ZOLL.
"We're especially pleased that major health agencies in China
recognize the value, reliability and consistency of our product
portfolio, and are using our defibrillators, AEDs and AutoPulse(R) to
improve outcomes from sudden cardiac arrest, the globe's leading cause
of unexpected death."

   Chinese Market Continues to Expand for ZOLL

   Installation of the M Series and the AED Plus follows an earlier
announcement that several major hospitals and EMS services in China
have installed ZOLL's AutoPulse(R) Non-invasive Cardiac Support Pump.
Four AutoPulse units will be onsite with Shenyang EMS during the
Olympic soccer games taking place in that city next month. Earlier in
the year, ZOLL announced that 80 AED Plus units were being installed
in newly-built Terminal 3 at Beijing International Airport, the
gateway terminal for the 2008 Beijing Summer Olympics.

   M Series--Compact, Lightweight Defibrillator for Easy Handling

   The small, rugged M Series is an easy-to-use portable unit packed
with power. With straightforward controls and optimal viewing
features, it provides everything for cardiac resuscitation:
defibrillation, external pacing and advanced monitoring capabilities.
Its 12-lead ECG data transmission provides clinicians with information
from the field to assess the patient's condition before arriving at
the hospital for improved diagnosis and treatment of patients.

   AED Plus--The Only Full-rescue AED

   The AED Plus supports the entire chain of survival and guides
rescuers through the life-saving process. It provides complete
instruction on whether and when to administer a defibrillating shock
and step-by-step CPR instructions using Real CPR Help(R). This
real-time auditory feedback coaches rescuers to provide the proper
rate and depth of chest compression to deliver the best manual CPR
possible.

   About Sudden Cardiac Arrest

   SCA claims more than 1 million lives each year worldwide. It is
the leading cause of unexpected death in the world and strikes without
warning. Currently, only about 5 percent of victims survive; 95
percent will die from SCA. SCA is an abrupt disruption of the heart's
function, which causes a lack of blood flow to vital organs.

   About ZOLL Medical Corporation

   ZOLL Medical Corporation is committed to developing technologies
that help advance the practice of resuscitation. With products for
pacing, defibrillation, circulation, ventilation, and fluid
resuscitation, ZOLL provides a comprehensive set of technologies,
including Real CPR Help and See-Thru CPR(R), that help clinicians, EMS
professionals, and lay rescuers resuscitate sudden cardiac arrest or
trauma victims. ZOLL also designs and markets software that automates
the documentation and management of both clinical and non-clinical
information.

   ZOLL markets and sells its products in more than 140 countries.
The Company has direct operations, distributor networks, and business
partners throughout the U.S., Canada, Latin America, Europe, the
Middle East and Africa, Asia, and Australia. 2008 marks the 25th
anniversary of ZOLL's resuscitation product development. For more
information, visit www.zoll.com.

   Certain statements contained in this press release, including
statements regarding the future business of the Company, and other
statements contained herein regarding matters that are not historical
facts, are "forward-looking" statements (as defined in the Private
Securities Litigation Reform Act of 1995). Because such statements are
subject to risks and uncertainties, actual results may differ
materially from those expressed or implied by such forward-looking
statements. Factors that could cause actual results to differ
materially from those expressed or implied by such forward-looking
statements include, but are not limited to, those factors discussed in
the section entitled "Risk Factors" in the Company's Quarterly Report
on Form 10-Q filed with the SEC on May 9, 2008. You should not place
undue reliance on the forward-looking statements in this press
release, and the Company disavows any obligation to update or
supplement those statements in the event of any changes in the facts,
circumstances, or expectations that underlie those statements.

   Copyright (C) 2008 ZOLL Medical Corporation. All rights reserved.
269 Mill Road, Chelmsford, MA 01824-4105. ZOLL, AED Plus, AutoPulse, M
Series, Real CPR Help, and See-Thru CPR are registered trademarks of
ZOLL Medical Corporation. All product names are the property of their
respective owners.

Investor Contact:
ZOLL Medical Corporation
A. Ernest Whiton, +1 978-421-9655
Chief Financial Officer
or
Media Contacts:
ZOLL Medical Corporation
Diane Egan, +1 978-421-9637
degan@zoll.com
or
Publicis Consultants / PR
Kim Angelastro, +1 212-527-8866
kim.angelastro@publicis-pr.com

Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.